Validation of the Index for Facial Angiofibromas: A new scoring tool to assess facial angiofibromas in the tuberous sclerosis complex

Affiliations

• ¹ Department of Pediatric Neurology and Developmental Medicine, University Children's Hospital Basel, Basel, Switzerland. Electronic address: patricia.dill@ukbb.ch.
• ² Department of Dermatology and Competence Centre for Rare Skin Disease, Saint-Eloi University Hospital of Montpellier, Montpellier, France.
• ³ Diagnostic Division, Dermatology Department, Bios Institute, Rome, Italy.
• ⁴ Department of Dermatology, Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), INSERM U1163, Paris-University, Imagine Institute, AP-HP5, Necker-Enfants Malades Hospital, Paris, France.
• ⁵ Department of Dermatology, University Hospital Basel, Basel, Switzerland.
• ⁶ Department of Pediatrics, Division of Child and Adolescent Neurology, University of Texas McGovern Medical School at Houston, Houston, Texas.
• ⁷ Department of Dermatology, University Clinic of Navarra, Madrid, Spain.
• ⁸ Department of Clinical Research, Medical Faculty, University of Basel, Basel, Switzerland; Clinical Trial Unit, Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
• ⁹ Department of Pediatric Neurology and Developmental Medicine, University Children's Hospital Basel, Basel, Switzerland.
• ¹⁰ Department of Neurocutaneous Medicine, Division of Health Science, Graduate School of Medicine, Osaka University, Japan.